MindImmune Strategic Investment — MindImmune

MindImmune, a company developing novel immunotherapies for neurological diseases, has secured a $5.0 million strategic investment. The funding round was led by [Investor Name, if mentioned] and will support the advancement of their lead drug candidate. This investment underscores the growing interest in innovative treatments for conditions like Alzheimer's and Parkinson's.